% alzhub.org library filter
% Source: https://alzhub.org/research?author=Greig+NH&status=peer-reviewed
% 22 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{greig2005-16275899,
  author  = {Greig, N. H. and Utsuki, T. and Ingram, D. K. and Wang, Y. and Pepeu, G. and Scali, C. and Yu, Q. S. and Mamczarz, J. and others},
  title   = {{Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent}},
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  year    = {2005},
  doi     = {10.1073/pnas.0508575102},
  pmid    = {16275899},
  url     = {https://doi.org/10.1073/pnas.0508575102}
}

@article{marutle2007-17640880,
  author  = {Marutle, A. and Ohmitsu, M. and Nilbratt, M. and Greig, N. H. and Nordberg, A. and Sugaya, K.},
  title   = {{Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserine}},
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  year    = {2007},
  doi     = {10.1073/pnas.0705346104},
  pmid    = {17640880},
  url     = {https://doi.org/10.1073/pnas.0705346104}
}

@article{tweedie2007-17908040,
  author  = {Tweedie, D. and Sambamurti, K. and Greig, N. H.},
  title   = {{TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets}},
  journal = {Current Alzheimer research},
  year    = {2007},
  doi     = {10.2174/156720507781788873},
  pmid    = {17908040},
  url     = {https://doi.org/10.2174/156720507781788873}
}

@article{greig2014-24529527,
  author  = {Greig, N. H. and Tweedie, D. and Rachmany, L. and Li, Y. and Rubovitch, V. and Schreiber, S. and Chiang, Y. H. and Hoffer, B. J. and others},
  title   = {{Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2014},
  doi     = {10.1016/j.jalz.2013.12.011},
  pmid    = {24529527},
  url     = {https://doi.org/10.1016/j.jalz.2013.12.011}
}

@article{lane2004-15190239,
  author  = {Lane, R. M. and Kivipelto, M. and Greig, N. H.},
  title   = {{Acetylcholinesterase and its inhibition in Alzheimer disease}},
  journal = {Clinical neuropharmacology},
  year    = {2004},
  doi     = {10.1097/00002826-200405000-00011},
  pmid    = {15190239},
  url     = {https://doi.org/10.1097/00002826-200405000-00011}
}

@article{becker2008-18953116,
  author  = {Becker, R. E. and Greig, N. H. and Giacobini, E.},
  title   = {{Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2008},
  doi     = {10.3233/jad-2008-15213},
  pmid    = {18953116},
  url     = {https://doi.org/10.3233/jad-2008-15213}
}

@article{kim2017-29113464,
  author  = {Kim, D. S. and Choi, H. I. and Wang, Y. and Luo, Y. and Hoffer, B. J. and Greig, N. H.},
  title   = {{A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway}},
  journal = {Cell transplantation},
  year    = {2017},
  doi     = {10.1177/0963689717721234},
  pmid    = {29113464},
  url     = {https://doi.org/10.1177/0963689717721234}
}

@article{bassil2017-28334990,
  author  = {Bassil, F. and Canron, M. H. and Vital, A. and Bezard, E. and Li, Y. and Greig, N. H. and Gulyani, S. and Kapogiannis, D. and others},
  title   = {{Insulin resistance and exendin-4 treatment for multiple system atrophy}},
  journal = {Brain : a journal of neurology},
  year    = {2017},
  doi     = {10.1093/brain/awx044},
  pmid    = {28334990},
  url     = {https://doi.org/10.1093/brain/awx044}
}

@article{kopp2022-36372278,
  author  = {Kopp, K. O. and Glotfelty, E. J. and Li, Y. and Greig, N. H.},
  title   = {{Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment}},
  journal = {Pharmacological research},
  year    = {2022},
  doi     = {10.1016/j.phrs.2022.106550},
  pmid    = {36372278},
  url     = {https://doi.org/10.1016/j.phrs.2022.106550}
}

@article{kerr2017-28190529,
  author  = {Kerr, J. S. and Adriaanse, B. A. and Greig, N. H. and Mattson, M. P. and Cader, M. Z. and Bohr, V. A. and Fang, E. F.},
  title   = {{Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms}},
  journal = {Trends in neurosciences},
  year    = {2017},
  doi     = {10.1016/j.tins.2017.01.002},
  pmid    = {28190529},
  url     = {https://doi.org/10.1016/j.tins.2017.01.002}
}

@article{perry2002-12183643,
  author  = {Perry, T. and Haughey, N. J. and Mattson, M. P. and Egan, J. M. and Greig, N. H.},
  title   = {{Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4}},
  journal = {The Journal of pharmacology and experimental therapeutics},
  year    = {2002},
  doi     = {10.1124/jpet.102.037481},
  pmid    = {12183643},
  url     = {https://doi.org/10.1124/jpet.102.037481}
}

@article{perry2003-12749025,
  author  = {Perry, T. and Lahiri, D. K. and Sambamurti, K. and Chen, D. and Mattson, M. P. and Egan, J. M. and Greig, N. H.},
  title   = {{Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron}},
  journal = {Journal of neuroscience research},
  year    = {2003},
  doi     = {10.1002/jnr.10611},
  pmid    = {12749025},
  url     = {https://doi.org/10.1002/jnr.10611}
}

@article{perry2002-11861804,
  author  = {Perry, T. and Lahiri, D. K. and Chen, D. and Zhou, J. and Shaw, K. T. and Egan, J. M. and Greig, N. H.},
  title   = {{A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells}},
  journal = {The Journal of pharmacology and experimental therapeutics},
  year    = {2002},
  doi     = {10.1124/jpet.300.3.958},
  pmid    = {11861804},
  url     = {https://doi.org/10.1124/jpet.300.3.958}
}

@article{salcedo2012-22519295,
  author  = {Salcedo, I. and Tweedie, D. and Li, Y. and Greig, N. H.},
  title   = {{Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders}},
  journal = {British journal of pharmacology},
  year    = {2012},
  doi     = {10.1111/j.1476-5381.2012.01971.x},
  pmid    = {22519295},
  url     = {https://doi.org/10.1111/j.1476-5381.2012.01971.x}
}

@article{perry2005-15974903,
  author  = {Perry, T. and Greig, N. H.},
  title   = {{Enhancing central nervous system endogenous GLP-1 receptor pathways for intervention in Alzheimer's disease}},
  journal = {Current Alzheimer research},
  year    = {2005},
  doi     = {10.2174/1567205054367892},
  pmid    = {15974903},
  url     = {https://doi.org/10.2174/1567205054367892}
}

@article{perry2004-15270203,
  author  = {Perry, T. A. and Greig, N. H.},
  title   = {{A new Alzheimer's disease interventive strategy: GLP-1}},
  journal = {Current drug targets},
  year    = {2004},
  doi     = {10.2174/1389450043345245},
  pmid    = {15270203},
  url     = {https://doi.org/10.2174/1389450043345245}
}

@article{rachmany2013-22892942,
  author  = {Rachmany, L. and Tweedie, D. and Li, Y. and Rubovitch, V. and Holloway, H. W. and Miller, J. and Hoffer, B. J. and Greig, N. H. and others},
  title   = {{Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in mice}},
  journal = {Age (Dordrecht, Netherlands)},
  year    = {2013},
  doi     = {10.1007/s11357-012-9464-0},
  pmid    = {22892942},
  url     = {https://doi.org/10.1007/s11357-012-9464-0}
}

@article{perry2002-12515900,
  author  = {Perry, T. and Greig, N. H.},
  title   = {{The glucagon-like peptides: a new genre in therapeutic targets for intervention in Alzheimer's disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2002},
  doi     = {10.3233/jad-2002-4605},
  pmid    = {12515900},
  url     = {https://doi.org/10.3233/jad-2002-4605}
}

@article{greig2004-15681814,
  author  = {Greig, N. H. and Mattson, M. P. and Perry, T. and Chan, S. L. and Giordano, T. and Sambamurti, K. and Rogers, J. T. and Ovadia, H. and others},
  title   = {{New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists}},
  journal = {Annals of the New York Academy of Sciences},
  year    = {2004},
  doi     = {10.1196/annals.1332.018},
  pmid    = {15681814},
  url     = {https://doi.org/10.1196/annals.1332.018}
}

@article{greig2001-11900310,
  author  = {Greig, N. H. and Utsuki, T. and Yu, Q. and Zhu, X. and Holloway, H. W. and Perry, T. and Lee, B. and Ingram, D. K. and others},
  title   = {{A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase}},
  journal = {Current medical research and opinion},
  year    = {2001},
  doi     = {10.1185/0300799039117057},
  pmid    = {11900310},
  url     = {https://doi.org/10.1185/0300799039117057}
}

@article{greig2002-12636181,
  author  = {Greig, N. H. and Lahiri, D. K. and Sambamurti, K.},
  title   = {{Butyrylcholinesterase: an important new target in Alzheimer's disease therapy}},
  journal = {International psychogeriatrics},
  year    = {2002},
  doi     = {10.1017/s1041610203008676},
  pmid    = {12636181},
  url     = {https://doi.org/10.1017/s1041610203008676}
}

@article{olivares2012-21875407,
  author  = {Olivares, D. and Deshpande, V. K. and Shi, Y. and Lahiri, D. K. and Greig, N. H. and Rogers, J. T. and Huang, X.},
  title   = {{N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease}},
  journal = {Current Alzheimer research},
  year    = {2012},
  doi     = {10.2174/156720512801322564},
  pmid    = {21875407},
  url     = {https://doi.org/10.2174/156720512801322564}
}